Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Avicanna Inc AVCNF


Primary Symbol: T.AVCN

Avicanna Inc. is a Canada-based commercial-stage international biopharmaceutical company. The Company's scientific platform commercializes over thirty products across various market segments: Medical Cannabis & Wellness Products (RHO Phyto), Pharmaceutical Pipeline and Medical Cannabis Care Platform (MyMedi.ca). RHO Phyto formulary offers a diverse range of proprietary formulations, including... see more

TSX:AVCN - Post Discussion

Avicanna Inc > This Revenue .
View:
Post by Shaft4300 on Aug 15, 2022 9:28pm

This Revenue .

Wow what a shite show.
Comment by Dagreedyanalyst on Aug 17, 2022 6:15pm
100% y-y? or the cost reduction? or the pharma companies giving them licensing fees, just curious....the market seemed to like it  Didnt you sell all your shares to buy Khiron cause it will be 50 cents before this hits 40.... wait this is now 39 and khiron 12 cents...move on with your like pal 
Comment by DowsingR0d on Jan 06, 2023 4:57pm
Stock price says otherwise - 0.50!
Comment by Shaft4300 on Jan 09, 2023 3:40pm
Hmmmmmm.....sell off...why...
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities